Anzeige
Mehr »
Freitag, 24.10.2025 - Börsentäglich über 12.000 News
Gold über 4.000 US-Dollar - Canary Gold startet Multi-Front-Exploration in Brasiliens neuem Gold-Hotspot
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40YEM | ISIN: US19207A2078 | Ticker-Symbol:
NASDAQ
23.10.25 | 21:26
15,810 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
COEPTIS THERAPEUTICS HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
COEPTIS THERAPEUTICS HOLDINGS INC 5-Tage-Chart

Aktuelle News zur COEPTIS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
03.10.Coeptis Therapeutics Holdings, Inc. - S-4/A, Registration of securities, business combinations1
01.10.Coeptis Therapeutics: Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage189BRISTOL, TN / ACCESS Newswire / October 1, 2025 / Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) today announced that The Vanderbilt Report has published coverage of the company following its recent...
► Artikel lesen
23.09.Vanderbilt Report and Coeptis Therapeutics: Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating2
12.09.Coeptis Therapeutics Holdings, Inc. - S-4/A, Registration of securities, business combinations1
14.08.Coeptis Therapeutics Holdings, Inc. - 10-Q, Quarterly Report2
09.08.Coeptis Therapeutics Holdings, Inc. - S-4/A, Registration of securities, business combinations-
22.07.Coeptis Therapeutics: Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd1
COEPTIS THERAPEUTICS Aktie jetzt für 0€ handeln
26.06.Coeptis Therapeutics: Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared2
26.06.Coeptis Therapeutics Holdings, Inc. - S-4, Registration of securities, business combinations-
03.06.Coeptis Therapeutics Holdings, Inc. - 10-K/A, Annual Report1
28.05.Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology1
14.05.Coeptis Therapeutics Holdings, Inc. - 10-Q, Quarterly Report2
25.04.Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement240WEXFORD, Pa., April 25, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) ("Coeptis" or the "Company"), a biopharmaceutical and technology company focused on developing innovative...
► Artikel lesen
27.12.24Coeptis Therapeutics, Inc.: Coeptis Therapeutics Announces Reverse Stock Split305WEXFORD, Pa., Dec. 27, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused...
► Artikel lesen
26.12.24Coeptis Therapeutics, Inc.: Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies451Coeptis Aims to Bring AI Innovation in Biotechnology and Technology WEXFORD, Pa., Dec. 26, 2024 /PRNewswire/ -- Coeptis Therapeutics Holdings, Inc. (Nasdaq:...
► Artikel lesen
03.12.24Coeptis Pharmaceuticals, Inc.: Coeptis Therapeutics Executes Binding Letter of Intent to Acquire Ai-powered Marketing Solutions for Biotech, Pharmaceutical and Other Industries167The Acquisition of NexGenAI Affiliates Network Expands Company's Capabilities and Drives Innovation, Operational Efficiency, and Opportunity for Growth WEXFORD...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1